FindTrial
Sign In

The value of ultrasound-guided percutaneous lung biopsy in the diagnosis of subpleural lung lesions: a prospective, multicenter, cohort study

The value of ultrasound-guided percutaneous lung biopsy in the diagnosis of subpleural lung lesions: a prospective, multicenter, cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032419
Enrollment
Unknown
Registered
2020-04-27
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subpleural lung lesions

Interventions

Group of US+CEUS:US+CEUS guided percutaneous lung biopsy
Group of US:US guided percutaneous lung biopsy
Group of CT:CT guided percutaneous lung biopsy

Sponsors

Tongji University Affiliated Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with subpleural pulmonary lesions detected by chest CT; 2. Patients who need to get a clear diagnosis for further diagnosis or treatment; 3. Patients who can not get the diagnosis result through sputum or blood culture and bronchoscopy.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiopulmonary failure; 2. Patients with coagulation dysfunction or who can't stop taking anticoagulant and antiplatelet drugs; 3. Pregnant women and minors.

Design outcomes

Primary

MeasureTime frame
Success rate of sampling;Diagnostic accuracy;—

Secondary

MeasureTime frame
False negative rate;Incidence of complications;Operation time;Puncture times;—

Countries

China

Contacts

Public ContactWang Yin

Tongji University Affiliated Shanghai Pulmonary Hospital

lpbbl@aliyun.com+86 13701885138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026